{
    "Trade/Device Name(s)": [
        "Sensititre 18-24 hour Susceptibility Plates",
        "Sensititre 18-24 hour MIC or Breakpoint Susceptibility System"
    ],
    "Submitter Information": "TREK Diagnostics Systems, Inc.",
    "510(k) Number": "K092445",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JWY",
        "LRG"
    ],
    "Summary Letter Date": "July 30, 2009",
    "Summary Letter Received Date": "August 10, 2009",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 866.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Minocycline"
    ],
    "Specimen Type(s)": [
        "Gram negative organisms",
        "Gram positive organisms",
        "Gram negative isolates",
        "Gram positive isolates"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Sensititre 18-24 hour Susceptibility system"
    ],
    "Method(s)/Technology(ies)": [
        "MIC (Minimum Inhibitory Concentration) determination",
        "Breakpoint susceptibility testing"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "System",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Minocycline addition for in vitro diagnostic susceptibility testing of Gram positive and Gram negative organisms.",
    "Indications for Use Summary": "In vitro diagnostic product for clinical susceptibility testing of aerobic and facultative Gram-negative and Gram-positive microorganisms including Escherichia coli, Klebsiella spp., Enterobacter aerogenes, Acinetobacter spp., and Staphylococcus aureus; not for treatment decision of staphylococcal infection.",
    "fda_folder": "Microbiology"
}